DE69005251D1 - Sulfatierte Glykosaminoglykuronane mit antithrombotischer Wirkung. - Google Patents

Sulfatierte Glykosaminoglykuronane mit antithrombotischer Wirkung.

Info

Publication number
DE69005251D1
DE69005251D1 DE90202449T DE69005251T DE69005251D1 DE 69005251 D1 DE69005251 D1 DE 69005251D1 DE 90202449 T DE90202449 T DE 90202449T DE 69005251 T DE69005251 T DE 69005251T DE 69005251 D1 DE69005251 D1 DE 69005251D1
Authority
DE
Germany
Prior art keywords
content
sulphate
sulphated
glycosaminoglykuronans
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE90202449T
Other languages
English (en)
Other versions
DE69005251T2 (de
Inventor
Houdenhoven Francois Egber Van
Huibert Cornelis Theus Moelker
Dirk Gerrit Meuleman
Adrianus Lambertus Mar Sanders
Dedem Gijsbert Willem Kare Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon NV
Original Assignee
Akzo Nv Arnheim/arnhem Nl
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv Arnheim/arnhem Nl, Akzo NV filed Critical Akzo Nv Arnheim/arnhem Nl
Application granted granted Critical
Publication of DE69005251D1 publication Critical patent/DE69005251D1/de
Publication of DE69005251T2 publication Critical patent/DE69005251T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DE90202449T 1989-10-04 1990-09-17 Sulfatierte Glykosaminoglykuronane mit antithrombotischer Wirkung. Expired - Lifetime DE69005251T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89202494 1989-10-04

Publications (2)

Publication Number Publication Date
DE69005251D1 true DE69005251D1 (de) 1994-01-27
DE69005251T2 DE69005251T2 (de) 1994-05-05

Family

ID=8202480

Family Applications (1)

Application Number Title Priority Date Filing Date
DE90202449T Expired - Lifetime DE69005251T2 (de) 1989-10-04 1990-09-17 Sulfatierte Glykosaminoglykuronane mit antithrombotischer Wirkung.

Country Status (16)

Country Link
US (1) US5164377A (de)
EP (1) EP0421508B1 (de)
JP (1) JP2655746B2 (de)
KR (1) KR0184260B1 (de)
AT (1) ATE98656T1 (de)
AU (1) AU637143B2 (de)
CA (1) CA2026036C (de)
DE (1) DE69005251T2 (de)
DK (1) DK0421508T3 (de)
ES (1) ES2062307T3 (de)
FI (1) FI101152B (de)
IE (1) IE64121B1 (de)
MX (1) MX9203786A (de)
NZ (1) NZ235440A (de)
PT (1) PT95511B (de)
ZA (1) ZA907495B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8826448D0 (en) * 1988-11-11 1988-12-14 Thrombosis Res Inst Improvements in/relating to organic compounds
SG67928A1 (en) * 1993-09-30 1999-10-19 Seikagaku Kogyo Co Ltd Antithrombotic
ATE315588T1 (de) * 1997-07-16 2006-02-15 Akzo Nobel Nv Verfahren zur herstellung von heparin
JP4915888B2 (ja) * 2001-08-01 2012-04-11 株式会社ジャパンエコロジーシンキング 豚皮抽出物よりのデルマタン硫酸の製造方法
FR2847256B1 (fr) * 2002-11-15 2005-04-08 Biochimie Appliquee Soc Nouveau procede d'obtention d'acide chondroitine sulfurique et ses utilisations
KR100786174B1 (ko) * 2005-07-06 2007-12-17 건양대학교산학협력단 돈족유래의 글리코스아미노글리칸을 포함하는 식품 조성물 및 이의 추출방법
US20110036133A1 (en) * 2008-04-18 2011-02-17 N. V. Organon Purification of protein hydrolysate and the result and products
CA3144968A1 (en) 2019-07-09 2021-01-14 Optimvia Llc Methods for synthesizing anticoagulant polysaccharides
EP4182452A1 (de) 2020-07-14 2023-05-24 Optimvia, LLC Verfahren zur synthese von nicht-antikoagulierendem heparansulfat

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE136572C (de) * 1902-12-05
CH460248A (fr) * 1963-02-21 1968-07-31 Joseph Malgouzou Guy Louis Procédé de traitement de tissus animaux, en vue de la séparation de polysaccharides acides contenus dans ces tissus
US3887703A (en) * 1967-03-24 1975-06-03 Oreal Mucopolysaccharides, their preparation and use in cosmetic and pharmaceutical compositions
DE2426586A1 (de) * 1973-06-14 1975-01-09 Opocrin Srl Verfahren zur herstellung von glukuronil-glukosamin-glykan-sulfaten mit antilipaemischer wirkung
JPS5151509A (de) * 1974-10-28 1976-05-07 Seikagaku Kogyo Co Ltd
IT1075117B (it) * 1977-02-14 1985-04-22 Fedeli Gianfranco Complesso polisaccaridico arterioso,processo per la sua preparazione e suo impiego in terapia umana
IT1158896B (it) * 1977-08-10 1987-02-25 Hepar Chimie Sa Esuronil esosaminoglicano solfato naturale, procedimento per la sua preparazione e impieghi terapeutici relativi
SE7811306L (sv) * 1978-11-01 1980-05-02 Rothman Gunnvor Antikoagulationsmedel samt sett for dess framstellning
DE3265781D1 (en) * 1981-05-21 1985-10-03 Akzo Nv New anti-thromboticum based on polysacharides, method for its preparation and pharmaceutical compositions
DE3244214A1 (de) * 1982-11-30 1984-05-30 B. Braun Melsungen Ag, 3508 Melsungen Verfahren zur reinigung und fraktionierung von heparin
FR2538404B1 (de) * 1982-12-28 1985-08-23 Anic Spa
US4745098A (en) * 1984-02-24 1988-05-17 The Regents Of The University Of California Compositions and method for improving wound healing
FR2572080B1 (fr) * 1984-10-18 1987-06-26 Dropic Procede de preparation de compositions de mucopolysaccharides dotees d'une activite antithrombotique elevee, les compositions obtenues et leur application en tant que medicaments
IT1208509B (it) * 1985-03-13 1989-07-10 Mediolanum Farmaceutici Srl Processo per la produzione di eparan solfato e dermatan solfato naturali sostanzialmente puri eloro impiego farmaceutico.
EP0209924A1 (de) * 1985-07-12 1987-01-28 Akzo N.V. Antithrombotikum auf Basis von Glykosaminoglykan, Verfahren zu dessen Herstellung und pharmazeutische Zusammensetzung
FR2584728B1 (fr) * 1985-07-12 1987-11-20 Choay Sa Procede de sulfatation de glycosaminoglycanes et de leurs fragments
AU7852687A (en) * 1986-08-21 1988-03-08 University Of Texas System, The Glycosaminoglycan derivatives and their use as inhibitors of tumor invasiveness or metastatic profusion
IT1213384B (it) * 1986-11-24 1989-12-20 Lab Derivati Organici Mediolan Processo per la preparazione controllata di gilcosaminoglicani a basso peso molecolare.
IT1217458B (it) * 1988-05-02 1990-03-22 Crinos Ind Farmacoriologica S Sulfoamino derivati di condroitin solfati,del dermatan solfato e dell' acido ialuronico e loro proprieta' farmacologiche

Also Published As

Publication number Publication date
KR910007532A (ko) 1991-05-30
US5164377A (en) 1992-11-17
IE903366A1 (en) 1991-04-10
EP0421508A3 (en) 1991-07-24
KR0184260B1 (ko) 1999-05-01
EP0421508A2 (de) 1991-04-10
DK0421508T3 (da) 1994-04-11
IE64121B1 (en) 1995-07-12
AU6323890A (en) 1991-04-11
FI904828A0 (fi) 1990-10-01
PT95511A (pt) 1991-08-14
ES2062307T3 (es) 1994-12-16
DE69005251T2 (de) 1994-05-05
FI101152B (fi) 1998-04-30
JPH03167127A (ja) 1991-07-19
CA2026036C (en) 2000-08-01
PT95511B (pt) 1997-07-31
EP0421508B1 (de) 1993-12-15
ZA907495B (en) 1991-07-31
AU637143B2 (en) 1993-05-20
MX9203786A (es) 1992-07-01
CA2026036A1 (en) 1991-04-05
NZ235440A (en) 1992-07-28
ATE98656T1 (de) 1994-01-15
JP2655746B2 (ja) 1997-09-24

Similar Documents

Publication Publication Date Title
SE9101957D0 (sv) Blandningar av polysackarider med laag molekylvikt samt framstaellning och anvaendning av desamma
IT8820412A0 (it) Sulfoamino derivati di condroitinsolfati, del dermatan solfato e dell'acido ialuronico e loro proprieta' farmacologiche.
IE811074L (en) Sulphated polysaccharides
IT1234826B (it) Derivati eparinici e procedimento per la loro preparazione
DE69005251D1 (de) Sulfatierte Glykosaminoglykuronane mit antithrombotischer Wirkung.
TW239148B (de)
IT1230582B (it) Oliogosaccaridi di dermatan solfato ed eparina aventi attivita' antiaterosclerotica
DE69813216T2 (de) Oligosaccharidemischungen mit antithrombotischer wirkung
ITMI912309A1 (it) Oligosaccaridi di dermatan solfato, processo per la loro produzione e relative composizioni farmaceutiche.
NO934044D0 (no) Genetisk kontroll av acetylering op pyruvylering av xantanbaserte polysakkaridpolymerer
DK0410326T3 (da) Genetisk styring af acetylering og pyruvylering af xanthangummi
IT1264101B1 (it) Processo per la sintesi di glicosaminoglicani semisintetici a struttura eparinica od eparanica modificati nella posizione 2
ITMI931175A1 (it) Polisaccaridi ad elevata attivita' antitrombotica e anticoagulante
PT81343A (fr) Procede de preparation de compositions de mucopolysaccharides dotees d'une activite antithrombotique elevee

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: AKZO NOBEL N.V., ARNHEIM/ARNHEM, NL

8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: N.V. ORGANON, OSS, NL